Fenofibrate and Calcinosis - a phase IV clinical study of FDA data

Summary:

Calcinosis is reported as a side effect among people who take Fenofibrate (fenofibrate), especially for people who are female, 60+ old, also take Crestor, and have Acromegaly.

The phase IV clinical study analyzes which people have Calcinosis when taking Fenofibrate. It is created by eHealthMe based on reports of 39,402 people who have side effects when taking Fenofibrate from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Calcinosis?

Calcinosis (calcium deposits in any soft tissue) is found to be associated with 411 drugs and 862 conditions by eHealthMe. Check the latest studies of Calcinosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

39,402 people reported to have side effects when taking Fenofibrate.
Among them, 12 people (0.03%) have Calcinosis.

Among these 12 people:

What is the gender of people who have Calcinosis when taking Fenofibrate? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Calcinosis when taking Fenofibrate? *

What are other drugs people take besides Fenofibrate? *

Crestor: 6 people, 50.00%
Provera: 5 people, 41.67%
Estrace: 5 people, 41.67%
Medroxyprogesterone Acetate: 4 people, 33.33%
Lopid: 2 people, 16.67%
Methotrexate: 2 people, 16.67%
Amlodipine Besylate: 2 people, 16.67%
Aspirin: 2 people, 16.67%
Atenolol: 2 people, 16.67%
Folic Acid: 2 people, 16.67%

What are other side effects people have besides Calcinosis? *

Diarrhea: 7 people, 58.33%
Gallstones (stone formation by bile component): 7 people, 58.33%
Fatigue (feeling of tiredness): 7 people, 58.33%
Back Pain: 7 people, 58.33%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 6 people, 50.00%
Kidney Stones: 6 people, 50.00%
Joint Pain: 6 people, 50.00%
Rashes (redness): 6 people, 50.00%
Drowsiness: 6 people, 50.00%
Muscle Aches (muscle pain): 6 people, 50.00%

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 5 people, 41.67%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 8.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
Renal Cell Carcinoma (a kidney cancer): 1 person, 8.33%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Nausea (feeling of having an urge to vomit): 1 person, 8.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 8.33%
Diabetes: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and have Calcinosis?

- Check whether Calcinosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fenofibrate:

Fenofibrate (40,457 reports)

Calcinosis treatments and more:

Calcinosis (3,651 reports)

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Calcinosis:

Calcinosis (411 drugs)

Browse all the conditions that are associated with Calcinosis:

Calcinosis (862 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Fenofibrate) and Fenofibrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.